|
|
|
|
Hairy Cell Leukemia
SuperGen Announces Results From Combination Study in CLL Published ... 14 Mar 2006
DG News Nipent(R) (pentostatin for injection) is currently approved as a single- agent treatment for patients with hairy cell leukemia and is not approved as either a ...
BioCryst Initiates Intravenous Peramivir Phase I Clinical Trial Mar 9, 2006
International News Service, Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ...
International Approvals: Alertec, Multiferon, Alvesco Feb 27, 2006
Medscape (subscription) ...to single-subtype, recombinant alpha-interferons in the treatment of hepatitis B and C, chronic myelogenous leukemia (CML), hairy cell leukemia (HCL), renal ...
RhoGTPases and p53 Are Involved in the Morphological Appearance ... Feb 14, 2006
Am J Pathology (subscription) Hairy cell leukemia is an uncommon B-cell lymphoproliferative disease of unknown etiology in which tumor cells display characteristic microfilamentous membrane ...
BioCryst Receives FDA Fast Track Designation for Peramivir Jan 17, 2006
Biotech Intelligence (press release), Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ...
Keryx Biopharmaceuticals, Inc. Announces Appointment of Senior ... Jan 4, 2006
PR Newswire (press release), ...well-known drugs, including: (1) intron-A(R) (recombinant interferon-alpha 2-b), for the treatment of malignant melanoma, hairy cell leukemia, AIDS-related ...
BioCryst Announces $30.0 Million Common Stock Offering to ... Dec 15, 2005
PR Newswire (press release), Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ...
Dacogen(TM) (Decitabine) Injection Complete Response Accepted for ... Dec 15, 2005
Genetic Engineering News, ...evaluated for the treatment of pancreatic cancer; Nipent(R) (pentostatin for injection), approved for the treatment of hairy-cell leukemia; Mitomycin, for use ...
SUPG: Nipent Studies Presented at ASH Dec 9, 2005
PharmaLive.com (press release), Nipent® is currently approved as a single-agent treatment for patients with hairy cell leukemia and is not approved as either a single agent or as part of a ...
Studies of Nipent in Combination Cancer Therapies for Treatment of ... Dec 9, 2005
PharmaLive.com (press release), Nipent(R) is currently approved as a single-agent treatment for patients with hairy cell leukemia and is not approved as either a single agent or as part of a ...
BioCryst to Present at the Bear Stearns 18th Annual Healthcare ... Sep 7, 2005
Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... Yahoo! News (press release)
Muleshoe football coach fought, conquered leukemia Aug 22, 2005
...to hear that it was. It was such a relief.". Wood, 43, was diagnosed with hairy cell leukemia in May. He went through one week of ... Amarillo.com (Subscription),
UPDATE 2-SuperGen leukemia drug marketing 'misleading'-FDA Aug 22, 2005
...company's promotional handouts did not include any information about the risks of the drug, which is approved to treat patients with active hairy cell leukemia ... Reuters
US FDA warns SuperGen over leukemia drug promotion Aug 22, 2005
...said the company's promotional handouts did not include any risk information about the drug, which is approved to treat patients with active hairy cell leukemia ... Reuters
Myeloid leukemia risk linked to obesity Aug 16, 2005
...fat-free mass and waist circumference, the risk of other blood cancers — such as multiple myeloma, lymphocytic leukemia, hairy cell leukemia, Hodgkin lymphoma ... Green Bay Press Gazette,
FDA Sends SuperGen Warning Letter Over Nipent Handout Aug 22, 2005
FDA-approved labeling (PI), Nipent is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia (HCL) patients ... PharmaLive.com (press release),
FDA halts SuperGen ads Aug 22, 2005
Nipent is an injectable treatment for hairy-cell leukemia, a rare blood disease that strikes mostly men and causes severe anemia and an enlarged spleen. ... San Jose Mercury News,
Muleshoe football coach fought, conquered leukemia -- Aug 22, 2005
...to hear that it was. It was such a relief.". Wood, 43, was diagnosed with hairy cell leukemia in May. He went through one week of ... / Amarillo.com (Subscription),
UPDATE 2-SuperGen leukemia drug marketing 'misleading'-FDA -- Aug 22, 2005
...company's promotional handouts did not include any information about the risks of the drug, which is approved to treat patients with active hairy cell leukemia ... / Reuters
BioCryst to Present at the Bear Stearns 18th Annual Healthcare ... -- Sep 7, 2005
Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... / Yahoo! News (press release)
US FDA warns SuperGen over leukemia drug promotion -- Aug 22, 2005
...said the company's promotional handouts did not include any risk information about the drug, which is approved to treat patients with active hairy cell leukemia ... / Reuters
Myeloid leukemia risk linked to obesity -- Aug 16, 2005
...fat-free mass and waist circumference, the risk of other blood cancers — such as multiple myeloma, lymphocytic leukemia, hairy cell leukemia, Hodgkin lymphoma ... / Green Bay Press Gazette,
FDA Sends SuperGen Warning Letter Over Nipent Handout -- Aug 22, 2005
FDA-approved labeling (PI), Nipent is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia (HCL) patients ... / PharmaLive.com (press release),
FDA halts SuperGen ads -- Aug 22, 2005
Nipent is an injectable treatment for hairy-cell leukemia, a rare blood disease that strikes mostly men and causes severe anemia and an enlarged spleen. ... / San Jose Mercury News,
BioCryst to Present at the Bear Stearns 18th Annual Healthcare ... Sep 7, 2005
Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... Yahoo! News (press release)
Muleshoe football coach fought, conquered leukemia Aug 22, 2005
...to hear that it was. It was such a relief.". Wood, 43, was diagnosed with hairy cell leukemia in May. He went through one week of ... Amarillo.com (Subscription),
UPDATE 2-SuperGen leukemia drug marketing 'misleading'-FDA Aug 22, 2005
...company's promotional handouts did not include any information about the risks of the drug, which is approved to treat patients with active hairy cell leukemia ... Reuters
US FDA warns SuperGen over leukemia drug promotion Aug 22, 2005
...said the company's promotional handouts did not include any risk information about the drug, which is approved to treat patients with active hairy cell leukemia ... Reuters
Myeloid leukemia risk linked to obesity Aug 16, 2005
...fat-free mass and waist circumference, the risk of other blood cancers — such as multiple myeloma, lymphocytic leukemia, hairy cell leukemia, Hodgkin lymphoma ... Green Bay Press Gazette,
FDA Sends SuperGen Warning Letter Over Nipent Handout Aug 22, 2005
FDA-approved labeling (PI), Nipent is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia (HCL) patients ... PharmaLive.com (press release),
FDA halts SuperGen ads Aug 22, 2005
Nipent is an injectable treatment for hairy-cell leukemia, a rare blood disease that strikes mostly men and causes severe anemia and an enlarged spleen. ... San Jose Mercury News,
BioCryst Receives FDA Fast Track Status for Fodosine(TM) in the ... -- Jun 20, 2005
...s lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... / mysan.de (Pressemitteilung),
Viragen's Multiferon approved for sale in Chile -- Jun 21, 2005
...interferons, Multiferon is primarily marketed for the treatment of hepatitis B, hepatitis C, chronic myelogenous leukemia, hairy cell leukemia, renal cell ... / Pharmaceutical Business Review
Viragen's Multiferon(R) Approved for Sale in Chile -- Jun 20, 2005
...interferons, Multiferon® is primarily marketed for the treatment of hepatitis B, hepatitis C, chronic myelogenous leukemia, hairy cell leukemia, renal cell ... / Yahoo News (press release)
Fillies continue a special spring -- Jun 10, 2005
It was an emotional loss for Sandburg coach Randy Couwenhoven, who coached the last four games of the season and is still battling hairy-cell leukemia. ... / Chicago Tribune,
Class AA Softball -- Jun 11, 2005
...for four more games," said an emotional but smiling Couwenhoven, who missed nearly two months of the season while undergoing treatment for hairy cell leukemia. ... / Chicago Daily Southtown,
Prep Softball: Class AA State Quarterfinals -- Jun 10, 2005
Couwenhoven, who was diagnosed with hairy cell leukemia at the beginning of the season, is just grateful to be back in the coaching box, enjoying his team's ... / Chicago Daily Southtown,
Pekin hitter suffers near-misses -- Jun 11, 2005
Couwenhoven recently notched his biggest victory. He rejoined the team earlier this month after an eight-week bout with hairy cell leukemia. ... / Peoria Journal Star,
BioCryst Pharmaceuticals Successfully Completes Phase I Trial With ... -- Mar 15, 2005
CTCL; chronic lymphocytic leukemia (CLL) and related leukemias including prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... / PR Newswire (press release)
Atypical Presentation of Anti-Rg a -- Mar 1, 2005
We report the case of a 70-yr-old man who presented with a medical history of hairy cell leukemia and profound pancytopenia that required RBC and platelet (PLT ... / Annals of Clinical & Laboratory Science,
Scripps site roulette propels murmurs at gala -- Feb 13, 2005
...courses, Lerner told the 750 attendees that scientists at Scripps developed the cure for one of the rarest forms of blood cancer, known as hairy-cell leukemia. ... / Palm Beach Post,
SuperGen Reports 2004 Fourth Quarter and Year-End Financial ... -- Feb 24, 2005
Nipent in combination with other chemotherapeutic agents, to treat chemotherapy-naove B-cell Chronic Lymphocytic Leukemia (CLL) and Hairy Cell Leukemia patients ... / PR Newswire (press release)
BioCryst Pharmaceuticals Successfully Completes Phase I Trial With ... Mar 15, 2005
CTCL; chronic lymphocytic leukemia (CLL) and related leukemias including prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... PR Newswire
Atypical Presentation of Anti-Rg a Mar 1, 2005
We report the case of a 70-yr-old man who presented with a medical history of hairy cell leukemia and profound pancytopenia that required RBC and platelet (PLT ... Annals of Clinical & Laboratory Science
Scripps site roulette propels murmurs at gala Feb 13, 2005
...courses, Lerner told the 750 attendees that scientists at Scripps developed the cure for one of the rarest forms of blood cancer, known as hairy-cell leukemia. ... Palm Beach Post
SuperGen Reports 2004 Fourth Quarter and Year-End Financial ... Feb 24, 2005
Nipent in combination with other chemotherapeutic agents, to treat chemotherapy-naove B-cell Chronic Lymphocytic Leukemia (CLL) and Hairy Cell Leukemia patients ... PR Newswire
Mitsubishi cuts jobs May 22, 2004
SuperGen said a pre-clinical study indicates that its anti-cancer drug Nipent, which is currently sold to treat patients with hairy cell leukemia, can also be ... San Mateo County Times
SuperGen Announces Study of Novel Regimen Using Nipent(R) for ... May 21, 2004
Nipent® is currently approved as a single-agent treatment for patients with hairy cell leukemia and is not approved as either a single agent or as part of a ... Yahoo News
SuperGen says study shows new use for drug May 21, 2004
...new, healthy cells in a person. Nipent is currently being sold to treat patients with hairy cell leukemia. It is in clinical trials ... East Bay Business Times
SuperGen Announces Study of Novel Regimen Using Nipent(R) for ... May 21, 2004
...role of pentostatin in preventing GVHD." About Nipent Nipent(R) is currently approved as a single-agent treatment for patients with hairy cell leukemia and is ... PR Newswire
The road to forgiveness May 21, 2004
Ward-Kaiser. She was just finishing chemotherapy after battling three types of cancer -- skin, breast, and hairy-cell leukemia. But ... Monterey County Herald
BioCryst Pharmaceuticals Initiates Oral Phase I Clinical Trial in ... -- Oct 19, 2004
...lymphoma; chronic lymphocytic leukemia (CLL) and related leukemias including prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... / Yahoo News (press release)
Simple Diagnostic Test for Hairy Cell Leukemia -- Aug 30, 2004
...published in The Lancet, a marker identified by gene profiling referred to as Annexin A1 (ANXA1) can help distinguish hairy cell leukemia from different kinds ... / Cancer Consultants (press release),
BioCryst Receives Orphan Drug Designation for BCX-1777 in Two ... -- Aug 24, 2004
...of chronic lymphocytic leukemia (CLL) and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for ... / Yahoo News (press release)
BIOCRYST CANCER COMPOUND RECEIVES ORPHAN DRUG STATUS FOR TWO ... -- Aug 24, 2004
...and for the treatment of chronic lymphocytic leukemia and related leukemias, including prolymphocytic leukemia, adult T-cell leukemia and hairy-cell leukemia. ... / Pharmexec (press release)
The strength to survive -- Aug 18, 2004
He was later tested and diagnosed with hairy-cell leukemia, a rare chronic form of the disease that weakens the immune system and makes the body extremely ... / Record-Journal,
Can Current Treatments for Advanced Non–Small-Cell Lung Cancer ... -- Jul 27, 2004
9 With a few notable exceptions, such as for the treatment of hairy-cell leukemia, combination chemotherapy has evolved as standard therapy for most neoplasms. ... / JAMA -
The hassle of getting records -- Aug 3, 2004
Q: I was diagnosed with ''hairy cell leukemia'' 12 years ago when I was living in Rhode Island. It went into remission, but I was ... / Miami Herald (subscription), FL -
Searching for information on drug trial held in Houston becomes a ... -- Jul 24, 2004
...leukemia. She was diagnosed eight years ago with chronic myelogenous leukemia. CML, for short. (I had hairy cell leukemia. It's ... / Houston Chronicle, TX -
|
|
|
